BioCardia (BCDA) Short-term Investments (2011 - 2017)
BioCardia's (BCDA) quarterly Short-term Investments came in at $1.8 million in Q3 2017, little changed quarter-over-quarter from $1.8 million in Q2 2017.
Powered by 
Analysis
BioCardia (BCDA) Short-term Investments (2011 - 2017) Analysis & Trends
BioCardia (BCDA) has reported Short-term Investments for 3 consecutive years, with $1.8 million the latest figure, recorded in Q3 2017.
- On a quarterly basis, Short-term Investments changed N/A year-over-year to $1.8 million in Q3 2017; TTM through Sep 2017 was $1.8 million, a N/A change from a year earlier, with the FY2011 full-year figure at $900000.0, changed N/A from the prior year.
- Short-term Investments was $1.8 million for Q3 2017 at BioCardia, roughly flat from $1.8 million in the prior quarter.
- Over five years, Short-term Investments peaked at $1.8 million in Q3 2017 and troughed at $1.8 million in Q2 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 1.80 Mn |
| Jun 30, 2017 | 1.80 Mn |
| Mar 31, 2012 | 900,000.00 |
| Dec 31, 2011 | 900,000.00 |
| Sep 30, 2011 | 1.22 Mn |
| Jun 30, 2011 | 1.46 Mn |